QualCast LLC Competitors

Optidata is a global cloud provider. Cloud without surprises: fixed, predictable pricing, no lock-in, and everything in one portal. 7,000+ active clients, 15+ petabytes processed, SOC 2 Type II certified — not just our facilities, but our company, processes and security controls, independently audited. Private Cloud & Managed Infrastructure — Where we built our reputation: dedicated, high-availability infrastructure for mission-critical operations, across 5+ cloud regions in the United States and Brazil, run by our own engineers for years. Optidata Neocloud — Our next chapter: fully self-service cloud. Deploy compute (high-availability instances in minutes), storage (block, object, snapshots and backups) and networking (VPCs, DNS, load balancer, firewall and anti-DDoS) straight from one portal, with transparent, fixed pricing. The entire platform — portal, orchestration and automation — is proprietary technology, developed in-house by Optidata and designed around the customer. Early access open at optidata.com. Dedicated GPUs — RTX 4000, 6000 and 8000 series, L40, H100 and more. The whole card is yours: dedicated hardware, your VRAM, at a fraction of the usual cloud cost. Optiwork — Our digital workspace product, with its own platform: collaboration, organization and productivity for your entire company, with built-in governance and security. Learn more at work.optidata.com. Cloud regions across the United States and Brazil. Miami is our newest region — and the first for Optidata Neocloud. We deliver the technology that sustains real growth, with stability and strategic vision.

At Formatech, we help make new drugs happen… at the speed of science! Formatech, founded in 1993, provides contract services that deliver unique solutions to our clients’ product development and manufacturing challenges. Our service offerings include: preformulation and formulation development of all common dosage forms, lyophilization development, cell culture/fermentation process development, purification/downstream process development and aseptic fill and finish of liquid and lyophilized dosage units. We have had excellent results developing biotherapeutic products. Our accomplishments include developing many Ab formulations at concentrations in excess of 200 mg/mL and an orally bioavailable peptide formulation. Our aseptic manufacturing facility produces liquid and lyophilized dosage units for clinical supplies or small-scale commercial products. Manufacturing support services include compounding/formulation, diafiltration/concentration (UF/DF), release testing, and ICH conforming stability programs. Our team is accomplished at completing new projects successfully even when confronted with very aggressive timelines. Our regulatory history includes FDA inspections and three inspections by the MHRA (letters and certificate of GMP compliance received).